These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28302348)

  • 1. Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
    Choi JW; Kim HC; Lee JH; Yu SJ; Cho EJ; Kim MU; Hur S; Lee M; Jae HJ; Chung JW
    J Vasc Interv Radiol; 2017 Jun; 28(6):795-803.e1. PubMed ID: 28302348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
    Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
    J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software.
    Miyayama S; Yamashiro M; Sugimori N; Ikeda R; Okimura K; Sakuragawa N
    J Vasc Interv Radiol; 2019 Jan; 30(1):10-18. PubMed ID: 30580809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    Choi YR; Chung JW; Yu MH; Lee M; Kim JH
    PLoS One; 2018; 13(9):e0203940. PubMed ID: 30231076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cone-beam CT hepatic arteriography in chemoembolization for hepatocellular carcinoma: angiographic image quality and its determining factors.
    Lee IJ; Chung JW; Yin YH; Kim HC; Kim YI; Jae HJ; Park JH
    J Vasc Interv Radiol; 2014 Sep; 25(9):1369-79; quiz 1379-.e1. PubMed ID: 24925087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone-Beam CT-Guided Chemoembolization in Patients with Complete Response after Previous Chemoembolization but Subsequent Elevated α-Fetoprotein without Overt Hepatocellular Carcinoma.
    Wattanasatesiri T; Kim HC; Choi JW; Lee JH; Joo I; Hur S; Lee M; Jae HJ; Chung JW
    J Vasc Interv Radiol; 2019 Aug; 30(8):1273-1280. PubMed ID: 31235410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma.
    Lucatelli P; Argirò R; Ginanni Corradini S; Saba L; Cirelli C; Fanelli F; Ricci C; Levi Sandri GB; Catalano C; Bezzi M
    J Vasc Interv Radiol; 2017 Jul; 28(7):978-986. PubMed ID: 28495451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?
    Kang HJ; Kim YI; Kim HC; Jae HJ; Hur S; Chung JW
    Korean J Radiol; 2015; 16(5):1068-78. PubMed ID: 26357501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
    Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
    Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Split-Bolus Single-Phase Contrast-Enhanced Cone-Beam CT for the Detection of Liver Tumors before Transarterial Chemoembolization.
    Jonczyk M; Chapiro J; Collettini F; Geisel D; Schnapauff D; Streitparth F; Schmidt T; Hamm B; Gebauer B; Wieners G
    J Vasc Interv Radiol; 2017 Oct; 28(10):1378-1385. PubMed ID: 28747271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Pung L; Ahmad M; Mueller K; Rosenberg J; Stave C; Hwang GL; Shah R; Kothary N
    J Vasc Interv Radiol; 2017 Mar; 28(3):334-341. PubMed ID: 28109724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
    Iwazawa J; Ohue S; Hashimoto N; Muramoto O; Mitani T
    Eur J Radiol; 2012 Dec; 81(12):3985-92. PubMed ID: 22959287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
    Park HJ; Kim JH; Choi SY; Lee ES; Park SJ; Byun JY; Choi BI
    AJR Am J Roentgenol; 2017 Oct; 209(4):W211-W220. PubMed ID: 28813195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization.
    Kakeda S; Korogi Y; Ohnari N; Moriya J; Oda N; Nishino K; Miyamoto W
    J Vasc Interv Radiol; 2007 Dec; 18(12):1508-16. PubMed ID: 18057285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.